In metastatic tumors, combining tumor CNA burden with TP53 or RB1 loss in multivariable analyses renders both slightly below conventional significance thresholds, raising the possibility of biological interplay between these genes (particularly TP53) and subsequent copy number alteration that develops during tumor evolution. The gene discussed is RB1; the disease is metastatic neoplasm.